Zobrazeno 1 - 10
of 8 816
pro vyhledávání: '"Avet Loiseau, H."'
Autor:
Perrot A; Service Hématologie, Toulouse University Hospital, Toulouse, France., Roussel M; Service Hématologie, Limoges University Hospital, Limoges, France., Lauwers-Cances V; UMSR, Toulouse University, Toulouse, France., Hulin C; Service Maladies du Sang, Bordeaux University Hospital, Bordeaux, France., Leleu X; Service Hématologie, Poitiers University Hospital, Poitiers, France., Touzeau C; Service Hématologie, Nantes University Hospital, Nantes, France., Facon T; Service Maladies du Sang, Lille University Hospital, Lille, France., Mariette C; Service Hématologie, Grenoble University Hospital, Grenoble, France., Schiano JM; Service Hématologie, Marseille Paoli-Calmettes Institute, Marseille, France., Gay J; Service Hématologie, Bayonne Cote Basque Hospital, Bayonne, France., Montes L; Service Hématologie, Amiens University Hospital, Amiens, France., Ranta D; Service Hématologie, Nancy University Hospital, Nancy, France., Huguet A; Département Recherche Clinique, Toulouse University Hospital, Toulouse, France., Wuillème S; Laboratoire d'Hematologie, Nantes University Hospital, Nantes, France., Dejoie T; Laboratoire de Biochimie, Nantes University Hospital, Nantes, France., Devlamynck L; UMSR, Toulouse University, Toulouse, France., Corre J; Toulouse Myeloma Genomic Unit, Toulouse, France., Avet-Loiseau H; Toulouse Myeloma Genomic Unit, Toulouse, France., Moreau P; Service Hématologie, Nantes University Hospital, Nantes, France., Attal M; Service Hématologie, Toulouse University Hospital, Toulouse, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 891-899. Date of Electronic Publication: 2024 May 29.
Publikováno v:
Cancer [Cancer] 2015 Mar 01; Vol. 121 (5), pp. 800.
Autor:
Leleu X; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France. xavier.leleu@chu-poitiers.fr., Hulin C; CHU, Bordeaux, France., Lambert J; SBIM, Saint-Louis Hospital, Paris, France., Bobin A; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Perrot A; University Hospital, iUCT Oncopole, Toulouse, France., Karlin L; Hôpital Lyon Sud, Pierre-Benite, France., Roussel M; Hematology, CHU, Limoges, France., Montes L; Hematology, CHU, Amiens, France., Cherel B; CH Bretagne Atlantique, Vannes, France., Chalopin T; Hematology, CHU, Tours, France., Slama B; Hospital center, Avignon, France., Chretien ML; Hematology, University Hospital, Inserm U1231, University of Burgundy Franche-Comté, Dijon, France., Laribi K; Hematology, CH, Le Mans, France., Dingremont C; Internal Medicine, Tarbes-Lourdes Hospital, Tarbes, France., Roul C; CH La Rochelle, La Rochelle, France., Mariette C; Hematology, CHU, Grenoble, France., Rigaudeau S; Hématologie - Le Chesnay, CH Versaille, Paris, France., Calmettes C; CH, Périgueux, France., Dib M; University Hospital, Angers, France., Tiab M; Hematology, CH Departemental de La Roche-sur-Yon, La Roche-sur-Yon, France., Vincent L; CHU, Montpellier, France., Delaunay J; Hôpital privé du confluent 2, Nantes, France., Santagostino A; Hematology, CH, Troyes, France., Macro M; Hematology, IHBN - CHU, Caen, France., Bourgeois E; GHICL, Lille, France., Orsini-Piocelle F; Hématologie, CH, Annecy Genevois, France., Gay J; Hematology, CH de la côte basque, Bayonne, France., Bareau B; Hematology, Les Hôpitaux Privés Rennais Cesson Sévigné - Vivalto Santé, Cesson Sévigné, France., Bigot N; SBIM, Saint-Louis Hospital, Paris, France., Vergez F; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Lebreton P; Hematology, CH, Le Havre, France., Tabrizi R; Hematology, CHI de Mont De Marsan, Mont-de-Marsan, France., Waultier-Rascalou A; Hematology, CHU, Nîmes, France., Frenzel L; Hematology, Necker Hospital, Paris, France., Le Calloch R; Hematology, CH de Cornouaille, Quimper Concarneau, Concarneau, France., Chalayer E; Hematology, CHU, Saint-Etienne, France., Braun T; Hematology, Avicenne hospital APHP, Bobigny, France., Lachenal F; CH Pierre Oudot, Bourgoin-Jallieu, France., Corm S; Medipole de Savoie, Challes les Eaux, France., Kennel C; CH William Morey, Chalon sur Saône, France., Belkhir R; Rheumatology, Hopital Bicetre, AP-HP, Universite Paris Saclay, Paris, France., Bladé JS; Onco-Hematology Department, HIA Sainte Anne, Toulon, France., Joly B; CH Sud Francilien, Corbeil Essonnes, France., Richez-Olivier V; CHU de Nice, Nice, France., Gardeney H; Hematology, CIC 1082, U1313, CHU, University, Poitiers, France., Demarquette H; Hematology, CH, Dunkerque, France., Robu-Cretu D; Hematology, CH, Lens, France., Garderet L; Hopital Pitié Salpetriere, hématologie APHP, Paris, France., Newinger-Porte M; Hôpital Emile Muller, Mulhouse, France., Kasmi A; DRC, CHU, Poitiers, France., Royer B; Hôpital Saint-Louis, Paris, France., Decaux O; Hematology, UMR U1236, University Hospital, Rennes, France., Arnulf B; Hôpital Saint-Louis, Paris, France., Belhadj K; C.H.U. Henri Mondor, Créteil, France., Touzeau C; Hématologie, CHU Hotel Dieu Université, Nantes, France., Mohty M; Hematology, Sorbonne University, Saint-Antoine Hôpital (AP-HP), UMRs 938, Paris, France., Manier S; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France., Moreau P; Hématologie, CHU Hotel Dieu Université, Nantes, France., Avet-Loiseau H; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Corre J; Unit for Genomics in Myeloma, iUCT Oncopole, Toulouse, France., Facon T; Hematology, University Hospital Inserm U-S1277 and CNRS UMR9020, Lille, France.
Publikováno v:
Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2235-2241. Date of Electronic Publication: 2024 Jun 03.
Publikováno v:
Blood [Blood] 2011 Jun 30; Vol. 117 (26), pp. 7188. Date of Electronic Publication: 2011 Apr 26.
Autor:
Samur MK; Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States., Aktas Samur A, Shah P; Dana Farber Cancer Institute, Harvard Medical School, United States., Park J; Dana Farber Cancer Institute, Boston, Massachusetts, United States., Fulciniti M; Dana Farber Cancer Institute, Boston, Massachusetts, United States., Shammas MA; Dana Farber Cancer Institute, Harvard Medical School, United States., Corre J; Unité de Genomique du Myélome, IUC- T Oncopole, TOULOUSE, United States., Anderson KC; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Parmigiani G; DFCI, Boston, United States., Avet-Loiseau H; IUCT-Oncopole Toulouse, Toulouse, France., Munshi NC; Dana Farber Cancer Institute, Boston, Massachusetts, United States.
Publikováno v:
Blood [Blood] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.
Autor:
Bobin A; University, U1313, U1402, Poitiers., Manier S; Department of Hematology, University hospital and INSERM UMR-S1277, Lille., De Keizer J; Clinical investigation center CIC INSERM 1402, University hospital, Poitiers., Srimani JK; Takeda Development Center Americas, Cambridge MA., Hulin C; Department of Hematology, Haut-Lévêque hospital, Pessac., Karlin L; Department of clinical Hematology, Civils Hospices, Lyon., Caillot D; Department of Oncology Hematology, Bourgogne Cancerology Institute, Dijon., Lafon I; Department of Oncology Hematology, Bourgogne Cancerology Institute, Dijon., Mariette C; Department of Hematology, University hospital, Grenoble., Araujo C; Department of Hematology, Côte basque hospital, Bayonne., Arnulf B; Department of Hematology, Saint-Louis hospital, Paris., Bareau B; Department of Hematology, private hospital, Cesson-Sévigné., Belhadj K; Lymphoid hemopathies Unit, Henri Mondor University hospital, Créteil., Benboubker L; Department of Hematology and cell therapy, Tours University hospital., Braun T; Department of clinical Hematology, Avicenne hospital, Bobigny., Calmettes C; Department of Onco-Hematology, hospital, Périgueux., Decaux O; Department of Clinical Hematology, UMR U1236 INSERM, University, Rennes., Dib M; Blood disease department, University hospital, Angers., Demarquette H; Department of Hematology, hospital, Dunkerque., Jacquet C; Department of Hematology, University hospital - Brabois hospitals, Vandoeuvre les Nancy., Sonntag C; Department of Hematology, ICANS University hospital, Strasbourg., Godet S; Department of clinical Hematology, University hospital, Robert Debré Hospital, Reims., Jaccard A; Department of clinical Hematology and cell therapy, University hospital, Limoges., Lenain P; Department of Hematology, Henri Becquerel center, Rouen., Macro M; Department of clinical Hematology, University hospital, Caen., Richez-Olivier V; Department of clinical Hematology, Archet hospital, Nice., Tiab M; Department of Onco-Hematology, Vendée departmental hospital, La Roche/Yon., Vincent L; Department of clinical Hematology, University, Montpellier., Zerazhi H; Department of Onco-Hematology, Henri Duffaut hospital, Avignon., Pétillon MO; Intergroupe Francophone du Myélome, Paris., Rollet S; Intergroupe Francophone du Myélome, Paris., Gardeney H; University, U1313, U1402, Poitiers., Durand G; University, U1313, U1402, Poitiers., Levy A; Department of Onco-Hematology, hospital, Vichy., Touzeau C; Department of clinical Hematology, University hospital, Hôtel Dieu, Nantes., Perrot A; Department of Hematology, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse., Moreau P; Department of clinical Hematology, University hospital, Hôtel Dieu, Nantes., Facon T; Department of Hematology, University hospital and INSERM UMR-S1277, Lille., Corre J; Unit for Genomics in Myeloma, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse., Ragot S; Clinical investigation center CIC INSERM 1402, University hospital, Poitiers., Avet-Loiseau H; Unit for Genomics in Myeloma, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse., Leleu X; University, U1313, U1402, Poitiers. xavier.leleu@chu-poitiers.fr.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Bazarbachi AH; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA. Electronic address: bazarbachi@gmail.com., Avet-Loiseau H; Cancer Research Center of Toulouse, INSERM, Myeloma Genomics Laboratory, University Cancer Institute Toulouse Oncopole, Université Paul Sabatier, Toulouse, France., Harousseau JL; Institut de Cancerologie de l'Ouest, Centre René Gauducheau, Nantes-St Herblain, France., Bazarbachi A; Department of Internal Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Mohty M; Sorbonne University, Service d'Hematologie Clinique et Thérapie Cellulaire, Hôpital Saint Antoine, and INSERM UMR 938, Paris, France. Electronic address: mohamad.mohty@inserm.fr.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2024 Nov; Vol. 130, pp. 102823. Date of Electronic Publication: 2024 Sep 03.
Autor:
Blanquart E; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Ekren R; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Rigaud B; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Joubert MV; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Baylot V; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Daunes H; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Cuisinier M; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Villard M; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France., Carrié N; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Mazzotti C; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Lucca LE; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Perrot A; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Corre J; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Walzer T; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France., Avet-Loiseau H; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France., Axisa PP; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France., Martinet L; Cancer Research Center of Toulouse, INSERM, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Toulouse, France.; Institut Universitaire du Cancer, Centre hospitalier universitaire de Toulouse, Toulouse, France.; Centre International de Recherche en Infectiologie, Université Lyon, Université Claude Bernard Lyon 1 INSERM U1111, Centre National de la Recherche Scientifique, UMR5308, École normale supérieure de Lyon, Université Jean Monnet de Saint-Etienne, Lyon, France.
Publikováno v:
Blood [Blood] 2024 Sep 19; Vol. 144 (12), pp. 1271-1283.
Autor:
Schavgoulidze A; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Perrot A; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.; Hematology Department, IUCT-Oncopole, Toulouse, France., Cazaubiel T; Hematology Department, University Hospital, Bordeaux, France., Leleu X; Hematology Department, University Hospital, Poitiers, France., Montes L; Hematology Department, University Hospital, Amiens, France., Jacquet C; Hematology Department, University Hospital, Nancy, France., Belhadj K; Hematology Department, University Hospital, Créteil, France., Brechignac S; Hematology Department, University Hospital, Bobigny, France., Frenzel L; Hematology Department, Necker University Hospital, Paris, France., Chalopin T; Hematology Department, University Hospital, Tours, France., Rey P; Hematology Department, Centre Léon Bérard, Lyon, France., Schiano de Collela JM; Hematology Department, Institut Paoli Calmettes, Marseille, France., Dib M; Hematology Department, University Hospital, Angers, France., Caillot D; Hematology Department, Institut de Cancérologie de Bourgogne, Dijon, France., Macro M; Hematology Department, University Hospital, Caen, France., Fontan J; Hematology Department, University Hospital, Besançon, France., Buisson L; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Pavageau L; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Roussel M; Hematology Department, University Hospital, Limoges, France., Manier S; Hematology Department, University Hospital, Lille, France., Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France., Martinet L; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Avet-Loiseau H; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Corre J; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France. corre.jill@iuct-oncopole.fr.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France. corre.jill@iuct-oncopole.fr.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Oct 26; Vol. 13 (1), pp. 160. Date of Electronic Publication: 2023 Oct 26.
Autor:
Herve Avet-Loiseau, Rémy Duléry
Publikováno v:
Cancer. 121:800-800
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::001035130e21032812617a221c8ffade
https://doi.org/10.1002/cncr.29151
https://doi.org/10.1002/cncr.29151